• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.在发生器囊袋处反复进行手术是植入式心脏复律除颤器感染的一个决定因素。
Clin Cardiol. 2017 Oct;40(10):892-898. doi: 10.1002/clc.22743. Epub 2017 Jun 21.
2
Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.感染性心内膜炎与心脏植入式电子设备植入术后死亡风险:一项全国性队列研究。
Europace. 2017 Jun 1;19(6):1007-1014. doi: 10.1093/europace/euw404.
3
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.植入型心律转复除颤器更换术后短期并发症的预测因素:安大略省 ICD 数据库的结果。
Circ Arrhythm Electrophysiol. 2011 Apr;4(2):136-42. doi: 10.1161/CIRCEP.110.959791. Epub 2011 Feb 15.
4
Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.需要手术修正的植入式设备并发症的发生率、原因及其对患者预后的影响:来自意大利两个中心的大型人群调查。
Europace. 2013 Apr;15(4):531-40. doi: 10.1093/europace/eus337. Epub 2013 Feb 13.
5
Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial.心脏除颤器植入后血肿:Shockless Implant Evaluation(SIMPLE)试验中的发生率和预测因素。
Europace. 2017 Jun 1;19(6):1002-1006. doi: 10.1093/europace/euw116.
6
Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.用于心脏性猝死一级预防的植入式心脏复律除颤器发生器更换后的结局
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):e003283. doi: 10.1161/CIRCEP.115.003283.
7
Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.与早期和晚期植入式心脏复律除颤器感染相关的危险因素。
J Interv Card Electrophysiol. 2011 Aug;31(2):171-83. doi: 10.1007/s10840-010-9537-x. Epub 2011 Mar 2.
8
Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.晚期复合装置感染增加是由心脏再同步化治疗除颤器感染所决定的。
Europace. 2015 Nov;17(11):1708-11. doi: 10.1093/europace/euv074. Epub 2015 Apr 16.
9
Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.心脏复律除颤器或心脏再同步治疗接受者的并发症:来自西里西亚中心除颤器登记处的见解。
Cardiol J. 2017;24(5):515-522. doi: 10.5603/CJ.a2016.0092. Epub 2016 Oct 13.
10
Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.性别差异在植入式心脏复律除颤器植入适应证和结局中的作用:来自以色列全国 ICD 登记处的经验。
Europace. 2014 Aug;16(8):1175-80. doi: 10.1093/europace/euu015. Epub 2014 Feb 19.

引用本文的文献

1
A comparison of different methods to maximise signal extraction when using central venous pressure to optimise atrioventricular delay after cardiac surgery.心脏手术后使用中心静脉压优化房室延迟时,不同方法最大化信号提取的比较。
Int J Cardiol Heart Vasc. 2024 Mar 12;51:101382. doi: 10.1016/j.ijcha.2024.101382. eCollection 2024 Apr.
2
Infection remediation after septic device extractions: analysis of three treatment strategies including a 1-year follow-up.感染性装置拔除后的感染修复:三种治疗策略分析及一年随访
Front Cardiovasc Med. 2024 Jan 11;10:1342886. doi: 10.3389/fcvm.2023.1342886. eCollection 2023.
3
Should they stay, or should they go: Do we need to remove the old cardiac implantable electronic device if a new system is required on the contralateral side?该留还是该去:如果对侧需要植入新的系统,我们是否需要移除旧的心脏植入式电子设备?
Heart Rhythm O2. 2022 Feb 13;3(2):169-175. doi: 10.1016/j.hroo.2022.02.005. eCollection 2022 Apr.
4
Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis.植入后囊袋血肿增加心脏植入式电子设备感染风险:一项荟萃分析。
J Arrhythm. 2021 Mar 13;37(3):635-644. doi: 10.1002/joa3.12516. eCollection 2021 Jun.
5
Strategies to Prevent Cardiac Implantable Electronic Device Infection.预防心脏植入式电子设备感染的策略
J Innov Card Rhythm Manag. 2020 Jan 15;11(1):3949-3956. doi: 10.19102/icrm.2020.110102. eCollection 2020 Jan.
6
Timing of device reimplantation and reinfection rates following cardiac implantable electronic device infection: a systematic review and meta-analysis.心脏植入式电子设备感染后再次植入和再感染率的时间:系统评价和荟萃分析。
BMJ Open. 2019 Sep 3;9(9):e029537. doi: 10.1136/bmjopen-2019-029537.
7
Successful defibrillation verification in subcutaneous implantable cardioverter-defibrillator recipients by low-energy shocks.皮下植入式心脏除颤器接受者通过低能量电击实现成功除颤验证。
Clin Cardiol. 2019 Jun;42(6):612-617. doi: 10.1002/clc.23184. Epub 2019 Apr 25.

本文引用的文献

1
Infections in Cardiac Implantable Electronic Devices: Diagnosis and Management in a Referral Center.心脏植入式电子设备感染:转诊中心的诊断与管理
Rev Esp Cardiol (Engl Ed). 2017 May;70(5):355-362. doi: 10.1016/j.rec.2016.09.031. Epub 2016 Dec 8.
2
Device Longevity in a Contemporary Cohort of ICD/CRT-D Patients Undergoing Device Replacement.当代接受设备更换的植入式心脏复律除颤器/心脏再同步化治疗除颤器(ICD/CRT-D)患者队列中的设备使用寿命
J Cardiovasc Electrophysiol. 2016 Jul;27(7):840-5. doi: 10.1111/jce.12990. Epub 2016 Jun 17.
3
Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.临床显著的囊袋血肿会增加器械感染的长期风险:BRUISE CONTROL INFECTION 研究。
J Am Coll Cardiol. 2016 Mar 22;67(11):1300-8. doi: 10.1016/j.jacc.2016.01.009.
4
Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.心脏植入式电子设备感染的危险因素:一项系统评价和荟萃分析。
Europace. 2015 May;17(5):767-77. doi: 10.1093/europace/euv053.
5
Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.晚期复合装置感染增加是由心脏再同步化治疗除颤器感染所决定的。
Europace. 2015 Nov;17(11):1708-11. doi: 10.1093/europace/euv074. Epub 2015 Apr 16.
6
Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.与使用抗菌封套作为心脏植入式电子设备植入护理标准相关的健康和经济结果
J Cardiovasc Electrophysiol. 2015 Jul;26(7):783-9. doi: 10.1111/jce.12684. Epub 2015 May 25.
7
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.植入式心脏复律除颤器患者的临床病程:关于临床结局、设备更换及设备相关并发症的扩展经验
Heart Rhythm. 2015 Jun;12(6):1169-76. doi: 10.1016/j.hrthm.2015.02.035. Epub 2015 Mar 4.
8
Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.200909 例 Medicare 植入式心脏复律除颤器植入患者的感染率和相关因素:来自国家心血管数据注册中心的结果。
Circulation. 2014 Sep 23;130(13):1037-43. doi: 10.1161/CIRCULATIONAHA.114.009081. Epub 2014 Jul 31.
9
Pacemaker or defibrillator surgery without interruption of anticoagulation.起搏器或除颤器手术不停抗凝治疗。
N Engl J Med. 2013 May 30;368(22):2084-93. doi: 10.1056/NEJMoa1302946. Epub 2013 May 9.
10
Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper.经静脉导线拔除的培训与认证途径:欧洲心律协会立场文件
Europace. 2012 Jan;14(1):124-34. doi: 10.1093/europace/eur338.

在发生器囊袋处反复进行手术是植入式心脏复律除颤器感染的一个决定因素。

Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.

作者信息

Arana-Rueda Eduardo, Pedrote Alonso, Frutos-López Manuel, Acosta Juan, Jauregui Beatriz, García-Riesco Lorena, Arce-León Álvaro, Gómez-Pulido Federico, Sánchez-Brotons Juan A, Gutiérrez-Carretero Encarnación, de Alarcón-González Arístides

机构信息

Arrhythmia Unit, Virgen del Rocío University Hospital, Seville, Spain.

Cardiac Surgery Unit, Virgen del Rocío University Hospital, Seville, Spain.

出版信息

Clin Cardiol. 2017 Oct;40(10):892-898. doi: 10.1002/clc.22743. Epub 2017 Jun 21.

DOI:10.1002/clc.22743
PMID:28636098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6490359/
Abstract

BACKGROUND

Rates of cardiac-device infections have increased in recent years, but the current incidence and risk factors for infection in patients with implantable cardioverter-defibrillators (ICDs) are not well known.

HYPOTHESIS

The increasing number of ICD infections is related to accumulated pocket manipulations over time.

METHODS

This single-center, prospective study included patients that underwent ICD implantation from 2008 to 2015. The endpoint was time to infection. Multivariate analysis was performed to identify independent risk factors related to infection.

RESULTS

The study included a total of 570 patients, of whom 419 (73.5%) underwent a first implantation. Mean age was 59 ± 14 years, and 80% were male. During a median follow-up of 36 months (interquartile range, 18-61 months; 1887 patient-years), infection was identified in 26 patients (4.56%), an incidence of 14.9 × 1000 patient-years. Median time to infection was 9.7 months (interquartile range, 1.35-23.4 months), and 38.5% were late infections (beyond 12 months of follow-up). In patients with replacement implants, the incidence was 3-fold higher than in first implantations (27.7 vs 9.1 × 1000 patient-years; P = 0.002). Cox regression identified 2 independent predictors of ICD infection: cumulative number of interventions at the generator pocket (hazard ratio: 1.92, 95% confidence interval: 1.42-2.6, P < 0.001) and pocket hematoma (hazard ratio: 7.0, 95% confidence interval: 2.7-17.9, P < 0.0001).

CONCLUSIONS

The incidence of infection in ICD patients is greater than previously reported, largely due to late infections. Each new cumulative intervention at the same generator pocket nearly doubles the risk of infection.

摘要

背景

近年来心脏设备感染率有所上升,但目前植入式心脏复律除颤器(ICD)患者的感染发生率及危险因素尚不清楚。

假设

ICD感染数量的增加与随着时间累积的囊袋操作有关。

方法

这项单中心前瞻性研究纳入了2008年至2015年接受ICD植入的患者。终点为感染时间。进行多变量分析以确定与感染相关的独立危险因素。

结果

该研究共纳入570例患者,其中419例(73.5%)接受首次植入。平均年龄为59±14岁,80%为男性。在中位随访36个月(四分位间距,18 - 61个月;1887患者年)期间,26例患者(4.56%)被确诊感染,感染发生率为14.9/1000患者年。感染的中位时间为9.7个月(四分位间距,1.35 - 23.4个月),38.5%为晚期感染(随访超过12个月)。在接受更换植入物的患者中,感染发生率比首次植入患者高3倍(27.7 vs 9.1/1000患者年;P = 0.002)。Cox回归确定了ICD感染的2个独立预测因素:发生器囊袋的累计干预次数(风险比:1.92,95%置信区间:1.42 - 2.6,P < 0.001)和囊袋血肿(风险比:7.0,95%置信区间:2.7 - 17.9,P < 0.0001)。

结论

ICD患者的感染发生率高于先前报道,主要归因于晚期感染。在同一发生器囊袋的每次新的累积干预使感染风险几乎增加一倍。